This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
Its that time of year again! Jade Teakell is leading team #UrineItToWinIt for #HCWvsHunger 2024. Read more.
This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
If you missed this weeks #NephJC chat and want a summary that takes less than 2 minutes to read, check out our second instalment by clicking the link!
Return of #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) January 29, 2022
✳️Rapid #NephJC catch-up✳️
Cochrane & KDIGO recommend children with steroid-sensitive nephrotic syndrome (SSNS) take low dose pred during upper resp tract infection (URTI) to ⬇️relapse risk, based on 4 small studies - does this hold up in a big RCT? pic.twitter.com/yGErtDE9Q6
Since we have two trials, we have two visual abstracts from the IPNA JC team, and NSMC faculty, Md Abdul Qader and S. Sudha Mannemuddhu
In addition, we also have Spanish versions! Thanks to Franklin Loachamin and Juan Kupferman for translating them:
